Clinical Trial Update: Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

View source ↗

Summary

An observational study of Epidyolex (cannabidiol) in Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex is currently recruiting in Italy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Lennox-gastaut Syndrome
• Tuberous Sclerosis Complex

Drugs mentioned

• Epidyolex (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Lennox Gastaut Syndrome, Dravet Syndrome | Status: RECRUITING